20/20 Biolabs, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINEPRE 14A20/20 Biolabs, Inc.AIDXOct 8

   20/20 Biolabs to hold virtual meeting on Dec 9, 2026

   • Special Meeting on Dec 9, 2026 at 10:00 a.m. Eastern Time
   • Virtual format via live webcast at https://edge.media-server.com/mmc/go/AIDX2026SGM
   • Proposals include reverse stock split and adjournment approval
2. ROUTINE8-K20/20 Biolabs, Inc.AIDXSep 18

   Current report

3. ROUTINE8-K20/20 Biolabs, Inc.AIDXSep 10

   Current report

4. ROUTINE8-K20/20 Biolabs, Inc.AIDXSep 2

   Current report

5. ROUTINEDEFA14A20/20 Biolabs, Inc.AIDXAug 19

   Additional proxy materials

6. ROUTINE8-K20/20 Biolabs, Inc.AIDXAug 19

   Current report

7. ROUTINE424B320/20 Biolabs, Inc.AIDXAug 17

   2 structured-note prospectuses

   Securities offering

   Show all 2

   • 424B3Securities offeringAug 17
   • 424B3Securities offeringAug 17
8. ROUTINE8-K20/20 Biolabs, Inc.AIDXAug 17

   Current report

9. NOTABLE10-Q20/20 Biolabs, Inc.AIDXAug 14

   Quarterly report

10. ROUTINE8-K20/20 Biolabs, Inc.AIDXAug 5

    Current report

11. ROUTINE8-K20/20 Biolabs, Inc.AIDXJul 22

    Current report

12. ROUTINE8-K20/20 Biolabs, Inc.AIDXJul 1

    Current report

13. ROUTINEDEF 14A20/20 Biolabs, Inc.AIDXJun 23

    Proxy statement

14. ROUTINEDEFA14A20/20 Biolabs, Inc.AIDXJun 23

    Additional proxy materials

15. ROUTINEPRE 14A20/20 Biolabs, Inc.AIDXJun 1

    Preliminary proxy statement

16. ROUTINE8-K20/20 Biolabs, Inc.AIDXMay 26

    Current report

17. ROUTINE424B320/20 Biolabs, Inc.AIDXMay 21

    2 structured-note prospectuses

    Securities offering

    Show all 2

    • 424B3Securities offeringMay 21
    • 424B3Securities offeringMay 21
18. NOTABLE10-Q20/20 Biolabs, Inc.AIDXMay 20

    Quarterly report

19. ROUTINE8-K20/20 Biolabs, Inc.AIDXMay 20

    Current report

20. NOTABLENT 10-Q20/20 Biolabs, Inc.AIDXMay 15

    Late quarterly report notice

21. ROUTINE424B320/20 Biolabs, Inc.AIDXApr 28

    2 structured-note prospectuses

    Securities offering

    Show all 2

    • 424B3Securities offeringApr 28
    • 424B3Securities offeringApr 28
22. ROUTINE8-K20/20 Biolabs, Inc.AIDXApr 28

    Current report

23. ROUTINE424B320/20 Biolabs, Inc.AIDXApr 13

    2 structured-note prospectuses

    Securities offering

    Show all 2

    • 424B3Securities offeringApr 13
    • 424B3Securities offeringApr 13
24. ROUTINEEFFECT20/20 Biolabs, Inc.AIDXApr 13

    Registration declared effective

25. ROUTINEEFFECT20/20 Biolabs, Inc.AIDXApr 10

    Registration declared effective

26. ROUTINE420/20 Biolabs, Inc.AIDXApr 6

    2 insider filings

    Alan B. Bergman, insider filing for AIDX

    Show all 2

    • 4Insider filing for AIDXApr 6
    • 4Insider filing for AIDXApr 6

    Alan B. Bergman, reporting

27. NOTABLES-120/20 Biolabs, Inc.AIDXApr 6

    Securities offering

28. ROUTINEPOS AM20/20 Biolabs, Inc.AIDXApr 6

    POS AM filing

29. NOTABLE10-K20/20 Biolabs, Inc.AIDXMar 31

    Annual report

30. ROUTINESCHEDULE 13G20/20 Biolabs, Inc.AIDXMar 10

    Ownership stake disclosure by Full Succeed International Ltd

    Full Succeed International Ltd, filed by

31. NOTABLESCHEDULE 13D20/20 Biolabs, Inc.AIDXMar 10

    Ownership stake disclosure by Jonathan M Cohen

    Jonathan M Cohen, filed by

32. ROUTINE420/20 Biolabs, Inc.AIDXMar 4

    Jonathan M Cohen, insider filing for AIDX

    Jonathan M Cohen, reporting

33. ROUTINE420/20 Biolabs, Inc.Feb 27

    John Woodson Rollins, insider filing for 20/20 Biolabs, Inc.

    John Woodson Rollins, reporting

34. ROUTINESCHEDULE 13G20/20 Biolabs, Inc.Feb 25

    Ownership stake disclosure by Streeterville Capital LLC

    Streeterville Capital LLC, filed by

35. ROUTINE420/20 Biolabs, Inc.Feb 23

    4 insider filings

    Michael A. Ross, insider filing for 20/20 Biolabs, Inc.

    Show all 4

    • 4Insider filing for 20/20 Biolabs, Inc.Feb 23
    • 4Insider filing for 20/20 Biolabs, Inc.Feb 23
    • 4Insider filing for 20/20 Biolabs, Inc.Feb 23
    • 3New insider at 20/20 Biolabs, Inc.Feb 23

    Michael A. Ross, reporting

36. ROUTINE320/20 Biolabs, Inc.Feb 19

    Jonathan M Cohen, new insider at 20/20 Biolabs, Inc.

    Jonathan M Cohen, reporting

37. ROUTINE424B320/20 Biolabs, Inc.Feb 18

    Securities offering

38. ROUTINEEFFECT20/20 Biolabs, Inc.Feb 18

    Registration declared effective

39. ROUTINE320/20 Biolabs, Inc.Feb 17

    4 insider filings

    Michael Saul Lebowitz, new insider at 20/20 Biolabs, Inc.

    Show all 4

    • 3New insider at 20/20 Biolabs, Inc.Feb 17
    • 3New insider at 20/20 Biolabs, Inc.Feb 17
    • 3New insider at 20/20 Biolabs, Inc.Feb 17
    • 3New insider at 20/20 Biolabs, Inc.Feb 17

    Michael Saul Lebowitz, reporting

Older filings on EDGAR